This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Bayer Pharmaceuticals Corporation, Bayer Healthcare LLC. Active years: 2007-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Albany, CA (US) (2007 - 2013)
- San Diego, CA (US) (2014 - 2016)
Company Filing History:
Years Active: 2007-2016
Title: Yongjian Wu: Innovator in Recombinant Protein Production
Introduction
Yongjian Wu is a prominent inventor based in Albany, CA (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 7 patents to his name, Wu's work has advanced the understanding and application of molecular chaperones in mammalian cells.
Latest Patents
One of Wu's latest patents focuses on the use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells. This invention relates to a method that increases the production of a secreted, recombinant protein product through the introduction of molecular chaperones in a mammalian host cell. Additionally, it describes a mammalian host cell with enhanced expression of a secreted recombinant protein product by coexpressing at least one chaperone protein.
Career Highlights
Throughout his career, Yongjian Wu has worked with notable companies such as Bayer Pharmaceuticals Corporation and Bayer Healthcare LLC. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in the pharmaceutical industry.
Collaborations
Wu has collaborated with several professionals in his field, including Yiwen Tao and Sham-Yuen Chan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Yongjian Wu's contributions to the field of biotechnology, particularly in the area of recombinant protein production, highlight his role as an influential inventor. His innovative approaches and collaborations continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
